Cellu Tissue Holdings, Inc. Prices Initial Public Offering
January 21 2010 - 11:31PM
PR Newswire (US)
ALPHARETTA, Ga., Jan. 21 /PRNewswire-FirstCall/ -- Cellu Tissue
Holdings, Inc. ("Cellu Tissue") has priced its initial public
offering of 8,300,000 shares of its common stock at $13.00 per
share. Cellu Tissue's common shares are expected to begin trading
on January 22, 2010 on the New York Stock Exchange under the ticker
symbol "CLU." In the offering, Cellu Tissue will sell 2,675,000
shares, while existing stockholders will sell 5,625,000 shares. The
underwriters have a 30-day option to purchase up to an additional
1,245,000 shares from the selling stockholders. Cellu Tissue will
not receive any of the proceeds from the sale of shares by the
selling stockholders. Cellu Tissue intends to use the net proceeds
it receives from the offering to pay down existing indebtedness,
including potentially, but not limited to, redeeming or
repurchasing a portion of its outstanding senior secured notes, and
repaying its outstanding acquisition promissory note. Goldman,
Sachs & Co. and J.P. Morgan Securities Inc. are serving as
joint book running managers for the offering, with BofA Merrill
Lynch, Baird, William Blair & Company and D.A. Davidson &
Co. acting as co-managers. The offering is only being made by means
of a prospectus, a copy of which may be obtained by contacting
either Goldman, Sachs & Co., at 85 Broad Street, New York, NY
10004, Attention: Prospectus Department, by telephone at
1-866-471-2526 or by emailing , or J.P. Morgan Securities Inc. c/o
Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood,
NY 11717, or by telephone at (866) 803-9204 . A registration
statement relating to these securities was declared effective by
the Securities and Exchange Commission on January 21, 2010. This
press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which the offer,
solicitation or sale of securities would be unlawful prior to their
registration and qualification under the securities laws of any
such state or jurisdiction. Cellu Tissue Holdings, Inc. is a North
American producer of consumer-oriented private label tissue
products with a growing presence in the value retail tissue market.
Information about Cellu Tissue Holdings, Inc. is available on the
Internet at http://www.cellutissue.com/. DATASOURCE: Cellu Tissue
Holdings, Inc. CONTACT: Investor Relations for Cellu Tissue
Holdings, Inc., +1-678-393-2651 Web Site:
http://www.cellutissue.com/
Copyright